Array Biopharma (ARRY) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.02 +0.72%
Revenue Growth %: -12.3%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: -12.3%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of ($0.17), $0.03 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $64.7 million versus the consensus estimate of $54.04 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Morgan Stanley Resumes Victoria Secret (VSXY) at Overweight
- Morgan Stanley turns cautious on freight stocks despite stronger cycle outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
